
Healthcare stocks fell hard on Wednesday following an update from CMS on its proposed CRUSH rule.
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| CI | Cigna | 285.37 | 27.27 | 10.56% |
| Name | Price | % Change | |
|---|---|---|---|
| $285.37 | +10.56% |

Healthcare stocks fell hard on Wednesday following an update from CMS on its proposed CRUSH rule.

The major averages were broadly lower near noon, adding to yesterday’s losses amid renewed selling in semiconductor stocks as the markets await Nvidia’s much-anticipated earnings report after the close. The

The Centers for Medicare and Medicaid Services announced a proposed rule that would “revise provisions regarding provider enrollment, medical review, investigations, and other program integrity oversight provisions to greatly strengthen”

The Centers for Medicare and Medicaid Services announced late Friday an “optional hold harmless period” for Medicaid through and including June 30, 2027. This provides states a “transition period to

Wells Fargo raised the firm’s price target on Cigna (CI) to $325 from $307 and keeps an Equal Weight rating on the shares. The firm is lowering 2027 / 2028

Jefferies raised the firm’s price target on Cigna (CI) to $304 from $288 and keeps a Hold rating on the shares. Q3 was “relatively as expected,” says the analyst, who

Piper Sandler analyst Jessica Tassan lowered the firm’s price target on Cigna (CI) to $360 from $370 and keeps an Overweight rating on the shares. The firm notes the company

Bernstein analyst Lance Wilkes raised the firm’s price target on Cigna (CI) to $390 from $387 and keeps an Outperform rating on the shares following quarterly results. The firm says

Barclays raised the firm’s price target on Cigna (CI) to $320 from $310 and keeps an Equal Weight rating on the shares. Published first on TheFly – the ultimate source

Cigna (($CI)) has held its Q3 earnings call. Read on for the main highlights of the call. Cigna’s third-quarter earnings call carried a strongly positive tone, with solid revenue and
| Name | Analyst | Analyst Firm | Rating | Analyst Price Target | Action | Date |
|---|---|---|---|---|---|---|
| hold | Reiterated | Nov 13, 2026 | ||||
| hold | Reiterated | Nov 12, 2026 | ||||
| buy | Reiterated | Nov 12, 2026 | ||||
| buy | Reiterated | Nov 11, 2026 | ||||
| hold | Reiterated | Nov 9, 2026 | ||||
| buy | Assigned | Nov 6, 2026 | ||||
| buy | Reiterated | Nov 6, 2026 | ||||
| buy | Reiterated | Nov 6, 2026 | ||||
| buy | Reiterated | Nov 5, 2026 | ||||
| buy | Reiterated | Nov 5, 2026 |
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| Feb 4, 2027TBA | $77.49B | $7.17 | $74.96B | 0.15 | 12.92 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.